2025-03-29 20:33:18
Latest Post
Bharat's largest solar cell manufacturing Gigafactory inaugurated by Waaree Energies in Chikhli, Gujarat
Purple Finance Limited sells portion of its portfolio to Ambit Finvest Pvt Ltd
Kumbhat Financial Services Limited allots 5.78 lakh shares to promoter Sanjay Kumbhat 
Solarium Green Energy Ltd receives order from BSF Jammu
RITES Ltd receives LoA from Oil India Ltd
Stock Report
Chemo Pharma Laboratories Ltd Q3FY23 profit at Rs. 16.19 lakhs
Posted On : 2023-01-31 21:43:12( TIMEZONE : IST )
CHEMO PHARMA LABORATORIES LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 0.1868 crores during the period ended December 31, 2022 as compared to Rs. 0.5901 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 0.1619 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 0.5341 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 1.08 for the period ended December 31, 2022 as compared to Rs. 3.56 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹0.1868 crs | ₹0.5901 crs |  -68.34% |
| Net Profit | ₹0.1619 crs | ₹0.5341 crs | -69.69% |
| EPS | ₹1.08 | ₹3.56 | -69.66% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.0.1868 crores during the period ended December 31, 2022 as compared to Rs.0.3613 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.1619 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.0.2791 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.1.08 for the period ended December 31, 2022 as compared to Rs.1.86 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹0.1868 crs | ₹0.3613 crs | -48.30% |
| Net Profit | ₹0.1619 crs | ₹0.2791 crs | -41.99% |
| EPS | ₹1.08 | ₹1.86 | -41.94% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.0.3940 crores during the 9 Months period ended December 31, 2022 as compared to Rs.0.6601 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.1953 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.0.4221 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.1.30 for the 9 Months period ended December 31, 2022 as compared to Rs.2.81 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹0.3940 crs | ₹0.6601 crs | -40.31% |
| Net Profit | ₹0.1953 crs | ₹0.4221 crs | -53.73% |
| EPS | ₹1.30 | ₹2.81 | -53.74% |
Shares of CHEMO PHARMA LABORATORIES LTD. was last trading in BSE at Rs. 39.00 as compared to the previous close of Rs. 39.50. The total number of shares traded during the day was 102 in over 9 trades.
The stock hit an intraday high of Rs. 39.00 and intraday low of 37.55. The net turnover during the day was Rs. 3863.00.
